Terry Smith acquired 1.65M Adma Biologics shares worth $14M. That's 0.10% of their equity portfolio (32nd largest holding). Terry Smith started to build up the position in Adma Biologics in Q4 2025. Since then they sold 453k shares. The investor's estimated purchase price is $27.9M, resulting in a loss of 50%.